Hēlo™ PE Thrombectomy System
Acute Pulmonary Embolism (PE)
PivotalActive
Key Facts
About Endovascular Engineering
Endovascular Engineering is a private, clinical-stage medical device company developing the Hēlo™ Thrombectomy System for pulmonary embolism. The company has completed a feasibility study and is currently running a pivotal FDA IDE trial (ENGULF) to support a 510(k) clearance. Backed by $42M in Series B financing and led by an experienced team, E2 aims to address a significant unmet need in the large and growing VTE market with a differentiated, purpose-built device.
View full company profileTherapeutic Areas
Other Acute Pulmonary Embolism (PE) Drugs
| Drug | Company | Phase |
|---|---|---|
| Integrated Monitoring & Infusion Catheter | Flow Medical | Development |